Paul Fonteyne - Director, Apellis Pharmaceuticals, Inc

As of January 4, 2021


Paul Fonteyne Net Worth

  • Net worth is estimated to be at least $428.95K
  • Owns at least 5,000 units of Apellis Pharmaceuticals, Inc stock

Paul Fonteyne Trading

  • Largest purchase of shares was 5,000 units , worth over $159.03K on May 12, 2020
  • In total has made about 3 transactions over a year
  • Usually trades in May, April and January, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Paul Fonteyne Mailing Address

  • Mailing address is C/o Restorbio, Inc. 501 Boylston Street Suite 6102 Boston MA 02116 MA

Apellis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Cedric Francois, M.D., Ph.D. 2020 $618,769 $429,687 $1,523,844 $6,703,125 - $9,275,425
Cedric Francois, M.D., Ph.D. 2019 $560,019 $427,893 - $3,279,270 - $4,267,182
Cedric Francois, M.D., Ph.D. 2018 $550,000 $381,562 - $3,127,600 $15,378 $4,074,540
Timothy Sullivan 2020 $430,269 $244,688 $518,129 $2,279,063 $13,000 $3,485,149
Timothy Sullivan 2019 $386,423 $214,730 - $1,108,650 $9,500 $1,719,303
Timothy Sullivan 2018 $380,000 $190,000 - $279,250 $10,502 $859,752
Pascal Deschatelets, Ph.D. 2020 $423,500 $239,062 $415,594 $1,828,125 $11,801 $2,918,082
Pascal Deschatelets, Ph.D. 2019 $404,077 $252,608 - $1,108,650 $55,893 $1,821,228
Pascal Deschatelets, Ph.D. 2018 $400,000 $225,000 - $1,228,700 $8,657 $1,862,357
Nur Nicholson 2020 $138,462 $150,068 - $2,648,750 $84,874 $3,022,154
Adam Townsend 2020 $430,038 $217,500 $415,594 $1,828,125 $9,750 $2,901,007
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm

Apellis Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 750 units sold on October 15, 2021 by Federico Grossi worth over $25.93K
  • In the last 4 years, insiders at Apellis Pharmaceuticals, Inc sold an estimated value of $36.34M and bought an estimated value of $82.31M
  • The most active traders are Federico Grossi, CHIEF MEDICAL OFFICER,  Cedric Francois, Chief Executive Officer,  and Alec MacHiels, Director
  • Insider trading is most common in February, with the busiest year in 2021

Apellis Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1